公司资料
LENSAR 股价、新闻与催化剂
- 股票代码:
- LNSR
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
8.44 USD (-3.21%)
收盘价
最后更新: 2026年8月20日
69.5M USD
市值
股价为何变动
As of Aug 20, 2026, LNSR closed down 3.21% at $8.44. No new same-company headline was identified in the current news window.
公司概览
Robotic Cataract Technology
LENSAR develops advanced laser systems for cataract surgery. Its technology is intended to automate key surgical steps and help ophthalmic surgeons plan and execute precise, astigmatism-aware procedures.
ALLY System
The ALLY Robotic Cataract Laser System combines imaging, planning and femtosecond-laser capabilities in a compact platform designed for use in the operating room. LENSAR places systems with ophthalmic practices and surgery centers, then generates recurring revenue from procedure-linked consumables, service and upgrades.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。